Preventing Cancer at the Cost of the Stomach: The Case of Patricia Fanlo Arnal
Patricia Fanlo Arnal eats white rice by the spoonful every two hours. She can't handle more. A year ago, she underwent a total gastrectomy despite not having cancer. She carries a lethal genetic mutation that has devastated her family for generations. Seventeen of her relatives have already gone through the same operating room. The uncomfortable question is whether it's worth trading a normal life for an existence of dietary restrictions, vitamin B12 supplements, and a bathroom always nearby.
A Decision Between Life and Quality of Life
The case has peine the debate on prophylactic surgery in healthy people. Hereditary gastric cancer associated with the CDH1 mutation is aggressive and usually appears between ages 20 and 40, often without symptoms until it's too late. Total gastrectomy eliminates the risk, but at a high functional cost. The stomach doesn't just store food: it produces acid, vitamin B12, and digestive hormones. Without it, the small intestine takes over digestion, but the patient must eat little and often, avoid sugars and fats, and inject B12 for life. Adaptation is possible, but it turns every meal into a calculation.
Criticism of the 'Preventive Fruta' Model
Not everyone applauds. A current of opinion sees this practice as a business: creating chronic patients from healthy people. It is compared to the case of Angelina Jolie, who underwent a double mastectomy due to genetic risk. Critics point out that individual probability is not certainty, and that preventive surgery is irreversible. They also question the reliability of genetic tests and the role of the medical industry. Others, however, argue that when you have seen your father, uncles, and cousins die of the same cancer, the decision is rational.
Living Without a Stomach: Day to Day
Accounts from those who have undergone the operation speak of a new normal. Fractioned meals, frequent bowel movements, risk of malnutrition. But also peace of mind: cancer won't come. Patricia was 41 when she had surgery – just when the mutation usually activates – and says she has sacrificed her life to save her life. A paradox that sums up the lights and shadows of predictive medicine.
Related Debates in the Forum